Testing a new drug in healthy volunteers
Treatments studied
This study tests a new medicine called Lu AH69593 in healthy people to see how safe it is and how the body handles it. Participants will stay at the clinic for a short time. This is an early-stage trial, so it may not directly help you, but it helps develop future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be generally healthy, based on medical history, physical exam, and lab tests.
- You must be able to attend all study visits and stay at the clinic from the start to the end of the study.
- You must not have taken another experimental drug within the last 2 months (or longer, depending on the drug).
- You must not have had a significant illness in the past 4 weeks.
- You must not have any major medical conditions (like heart, lung, kidney, or psychiatric disorders).
- For Part B: you must not have certain genetic markers (HLA-B*15:02 or HLA-A*31:01) or a personal or family history of severe skin reactions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether a common antifungal drug (itraconazole) affects how the body processes a new experimental medicine (HS-10506). The goal is to see if the two drugs can be used together safely.
This study tests a new medicine called KS101 to see if it is safe and how it works in healthy people for the first time. It is a first-in-human trial, meaning this is the first time the drug is given to people, and your health will be closely monitored throughout.
This study tests a new medicine (INCA033989) given as a shot or IV in healthy adults to see how the body processes it and if it's safe.
This trial tests a new medicine in healthy men to see how the body absorbs, breaks down, and removes it. This helps doctors understand how the drug works, which may lead to better treatments in the future.
This trial tests a new oral medication in healthy volunteers to see how it moves through the body and how safe it is. Taking part helps researchers understand how the drug works before it's studied in people with a certain condition.
This trial tests how SIM0270 interacts with other drugs (itraconazole, rifampin, midazolam) in healthy Chinese adults. It helps doctors understand if SIM0270 is safe and how it works in the body.
Hear when a new Healthy Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.